These results suggest that BCL2, LAIR1, and CD11c and BCL6 could be used to discriminate DLBCL cells from normal B cells during MFC analysis of dissociated tumor samples. The gene discussed is ITGAX; the disease is diffuse large B-cell lymphoma.